Semuloparin sodium

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameSemuloparin sodium
Drug Alias NameOctaparinMulsevoVisamerinAVE-5026
ClassificationSmall molecules > Carbohydrate
Mechanisms of ActionAntithrombin-III activatorsFactor Xa inactivationThrombin inactivation
TargetsAntithrombin-IIIProthrombinCoagulation factor X
Therapy Area/IndicationsThrombosisVenous ThromboembolismNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumBulgaria +[54] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaPending
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofi
Active IndicationsN/A
Inactive IndicationsThrombosisVenous ThromboembolismNeoplasms

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG